Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

BRAVE-DREAMS (BRAin VEnous DRainage Exploited Against Multiple Sclerosis) (BRAVE-DREAMS)

This study has been completed.
Sponsor:
Collaborator:
Regione Emilia-Romagna
Information provided by (Responsible Party):
Paolo Zamboni, S. Anna Hospital
ClinicalTrials.gov Identifier:
NCT01371760
First received: June 7, 2011
Last updated: December 16, 2015
Last verified: December 2015